Abstract
Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Keywords: Connexin, gap junction, carcinogenesis, cancer
Current Signal Transduction Therapy
Title: The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Volume: 2 Issue: 1
Author(s): Kanczuga-koda Luiza, Sulkowski Stanislaw, Koda Mariusz, Wincewicz Andrzej, Rutkowski Tadeusz and Moniuszko Mariola
Affiliation:
Keywords: Connexin, gap junction, carcinogenesis, cancer
Abstract: Gap junctional intercellular communication is a mechanism for direct cell-to-cell signaling and is mediated by gap junctions, which consist of transmembrane proteins called connexins. Many physiological roles have been proposed for gap junctions such as maintenance of tissue homeostasis, regulation of tissue development, electrical and metabolic coupling as well as regulation of cellular growth, differentiation and apoptosis. Signaling is especially altered via gap junctions in cancer. Furthermore, these membrane channels are believed to be engaged in metastasis. Involvement of aberrant gap junctional intercellular communication in carcinogenesis and tumor suppressing role of connexin genes has been well documented. However, clear explanation is required for the role of connexins that are localized in intracellular compartment of cancerous cells and participate in apoptosis and metastasis as well. The present review is confined to role of connexins in a cell signaling during carcinogenesis, regulation of apoptosis and involvement in metastasis. Potential role of gap junctions and connexins in therapy of cancers was analyzed, too.
Export Options
About this article
Cite this article as:
Luiza Kanczuga-koda, Stanislaw Sulkowski, Mariusz Koda, Andrzej Wincewicz, Tadeusz Rutkowski and Mariola Moniuszko, The Role of Connexins in Carcinogenesis: Review of Current Knowledge, Current Signal Transduction Therapy 2007; 2 (1) . https://dx.doi.org/10.2174/157436207779317074
DOI https://dx.doi.org/10.2174/157436207779317074 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Overview on the Pharmacokinetics of Quantum Dots
Current Drug Metabolism Identification of a Novel Peptide Ligand of Human Transfrrin Receptor 1 for Targeted Tumor Delivery Drug
Protein & Peptide Letters Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine
Anti-Cancer Agents in Medicinal Chemistry Nucleic Acids as Therapeutic Agents
Current Topics in Medicinal Chemistry Antibody-Targeted Immunoliposomes for Cancer Treatment
Mini-Reviews in Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry The Role of Angiogenesis as a Prognostic Factor of Breast Cancer: Recent Review
Current Women`s Health Reviews The Use of Nimesulide and Its Analogues in Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Selenium and Selenoproteins: An Overview on Different Biological Systems
Current Protein & Peptide Science Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Surface Antigens/Receptors for Targeted Cancer Treatment: The GnRH Receptor / Binding Site for Targeted Adenocarcinoma Therapy
Current Cancer Drug Targets Diabetes-induced Epigenetic Signature in Vascular Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-tumor Drug Targets Analysis: Current Insight and Future Prospect
Current Drug Targets Polyphenolic Compounds: Interactions with the Gut and Implications for Human Health
Current Medicinal Chemistry Multiple Myeloma and the Immune Microenvironment
Current Cancer Drug Targets Heterologous Production of Death Ligands’ and Death Receptors’ Extracellular Domains: Structural Features and Efficient Systems
Protein & Peptide Letters ADAM Proteins- Therapeutic Potential in Cancer
Current Cancer Drug Targets The Anti-Tumor Activity of Afatinib in Pancreatic Ductal Adenocarcinoma Cells
Anti-Cancer Agents in Medicinal Chemistry Regulation of Tumor Immune Microenvironment by Sphingolipids and Lysophosphatidic Acid
Current Drug Targets Vitamin D and Vitamin D Analogs in Cancer Treatment
Current Drug Targets